A1RG34:BVMF
Argenx Se Bdr
R$203.40
0.00%
(0.00) 1D
Sep 28, 4:29:16 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
59.62B
Avg. vol.
51.00
Volume
0.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
Mkt. cap
59.62B
Avg. vol.
51.00
Volume
0.00
52-wk high
R$213.15
52-wk low
R$143.22
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
TipRanks
·
2 hours ago
Argenx Unveils New VYVGART and Pipeline Data at AANEM and MGFA
Stock Titan
·
3 hours ago
For myasthenia gravis, treatment within a year of diagnosis brought a 4.7-point symptom drop in three months.
Yahoo Finance
·
15 hours ago
argenx SE (ARGX) Stock Forecasts
AD HOC NEWS
·
19 hours ago
argenx stock closes at EUR 844.60 on September 28, 2026, down 0.07 percent
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr